COSM Cosmos Health Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
16:58
Jan 20
Jan 20
Undervalued microcap with insider buying and $40M expansion
The author argues Cosmos Health is undervalued with a market cap under $25M against $50M+ in annual sales, and that a robotic expansion at Cosmofarm supporting an additional $40M in annual revenue is not yet priced in. Catalysts cited include CEO Grigorios Siokas accumulating millions of shares including a recent 493,495-share debt-exchange purchase, improving unit economics (revenue per customer +12%, profitability per customer +14%), a Zacks Small-Cap Research $4.50 valuation versus a ~$0.50-0.60 stock price, and unusual volume. Main stated risk is the need to maintain Nasdaq $1.00 compliance.
HIGH
21:58
Jan 15
Jan 15
CEO insider buying and operational catalysts suggest a potential price reversal.
CEO Grigorios Siokas is systematically increasing his equity stake by converting debt to shares, signaling strong confidence in the company's future. The company is also improving its balance sheet through a $300M treasury management partnership and expanding its product line with a new manufacturing agreement. The author expects a potential price move toward $1.00 if the stock breaks through $0.65 resistance, though notes high volatility as a primary risk.
HIGH
About COSM Investor Commentary
Across the available history and selected sources, Buzzberg tracks COSM (Cosmos Health Inc.) across 1 sources: 2 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/Impossible-Hair1343.